The objective of the study is to provide the European Commission with the necessary information and analysis in support of the evaluation of the 2 EU Regulations on Drug Precursors (273/2004 and 111/2005). The study results will be used in the preparation of the report on the implementation and functioning of the Regulations on drug precursors, which the Commission must submit by 31.12.2019 to the European Parliament and to the Council. In order to fulfil its objective, the study requires the following tasks to be carried out, in line with the Better Regulation principles:

1. Establishment of the evaluation methodology;

2. Providing information on the implementation and assessing the effectiveness, efficiency, coherence, relevance and EU added value of the Regulations;

3. Assessing the need for additional action to monitor and control suspicious transactions with non-scheduled substances;

4. Stakeholders consultation and open public consultation;

5. Validation workshop.

Service contract for a study. The objective is to provide the European Commission with the necessary information and analysis in support of the evaluation of the 2 EU Regulations on Drug Precursors (273/2004 and 111/2005). The study results will be used in the preparation of the report on the implementation and functioning of the Regulations on drug precursors, which the Commission must submit by 31.12.2019 to the European Parliament and to the Council. In order to fulfil its objective, the study requires the following tasks to be carried out, in line with the Better Regulation principles:

Task 1 — Establishment of the evaluation methodology;

Task 2 — Providing information on the implementation and assessing the effectiveness, efficiency, coherence, relevance and EU added value of the Regulations;

Task 3 — Assessing the need for additional action to monitor and control suspicious transactions with non-scheduled substances;

Task 4 — Stakeholders consultation and open public consultation;

Task 5 — Validation workshop.